Adamis Pharmaceuticals Corp - FORM 10-K - EX-10.72 - LEASE AGREEMENT - April 15, 2021

Attached files

file filename
10-K - ANNUAL REPORT - Adamis Pharmaceuticals Corpadmp-10k_123120.htm
EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex32-2.htm
EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex32-1.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex31-2.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex31-1.htm
EX-23.2 - CONSENT OF MAYER HOFFMAN MCCANN P.C. - Adamis Pharmaceuticals Corpex23-2.htm
EX-23.1 - CONSENT OF BDO USA, LLP - Adamis Pharmaceuticals Corpex23-1.htm
EX-21.1 - SUBSIDIARIES - Adamis Pharmaceuticals Corpex21-1.htm
EX-10.73 - PROMISSORY NOTE DATED MARCH 15, 2021 - Adamis Pharmaceuticals Corpex10-73.htm
EX-10.20 - FIRST AMENDMENT TO LEASE - Adamis Pharmaceuticals Corpex10-20.htm
EX-4.6 - DESCRIPTION OF CAPITAL STOCK - Adamis Pharmaceuticals Corpex4-6.htm
 

Adamis Pharmaceuticals Corporation 10-K

  

Exhibit 10.72

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 

 

 

 
 

 

 

 

 

 

Stock widget

Investing forum

Adamis Pharmaceuticals Corp Reports